Taken together, this highlights the importance of ARMH1 as EZH2 interactant at the post-translational level and provides insights into its involvement in high-risk factors and therapeutic resistance mechanisms, in pediatric AML. The gene discussed is EZH2; the disease is acute myeloid leukemia.